Filing Details
- Accession Number:
- 0001209191-23-003338
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-13 18:20:08
- Reporting Period:
- 2023-01-11
- Accepted Time:
- 2023-01-13 18:20:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434316 | Fate Therapeutics Inc | FATE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238362 | John Mendlein | C/O Fate Therapeutics, Inc. 12278 Scripps Summit Drive San Diego CA 92131 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-11 | 88,048 | $5.67 | 246,139 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2023-01-13 | 36,631 | $5.43 | 282,770 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
